“…Meanwhile, some of these reports lack quality and will require validation. Bioactive compounds identified in the plants include; for V. amygdalina - vernolide (116), vernodalin (117), hydroxyvernolide (120) and vernodalol (123), vernoniosides B1-B3 and vernoniosides A1-A4 (124) ; for N. pobeguinii - strictosamide (138), 19-O-methylangustoline, angustoline (139) , A. Mexicana - berberine (140), tetrahydroberberine, protopine (141), benzophenanthridines, 8-acetonyl dihydrosanguiranine, 8-methoxy dihydrosanguiranine (142) , pancorine (144) , O-methylzanthoxyline (145) , nor-chelerythrine (125) , arnottianamide (146) cryptopine (147) , muramine (148) , argemexicaine A, argemexicaine B (149) ; for A. annua - artemisinin (157) ; C. aurantiifolia - apigenin (156) and Morinda lucida - Morindin (154), oruwal (152), oruwalol (155), oruwacin (150), molucidin (151), Damnacanthal (153), Ursolic acid (17), polypeptides ( Kraft et al, 2003 ; Challand and Willcox, 2009 ; Brahmachari et al, 2013 ; Haidara et al, 2016 ; Haudecoeur et al, 2018 ; Divneet Kaur, 2019 ). Overwhelming evidence supports the standardization of the leaf and seed of M. oleifera for a possible clinical application [ Level III ] as it has demonstrated broad range of antiviral activity in various studies ( Biswas D. et al, 2020 ) while the disulphide-stabilized miniproteins (Morintides), lectins, hevein-like peptides, protein hydrolysates and glucosinolates/isothiocynates isolated from the plant have shown impressive effects, including as antiadhesives, anti-inflammatory, antioxidants and immunomodulatory compounds ( Kini et al, 2017 ; Moura et al, 2017 ; Coriolano et al, 2018 ; Fahey et al, 2019 ; Liang et al, 2019 ; Sousa et al, 2020 ).…”